NIH-funded research R01 grant

Lowering cholesterol to improve immune response in prostate cancer

Official title: Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer

Funded at Cedars-Sinai Medical Center · NIH-10933005 · Data updated 2026-11-12

This study is looking at whether lowering cholesterol can help boost the immune system's ability to fight prostate cancer, and it involves both animal tests and human trials to see how this change affects important immune cells.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 21, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$657,403
NIH project number5R01CA280060-02
Project IDNIH-10933005 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are prostate cancer patients who are undergoing treatment and may benefit from cholesterol-lowering interventions.

Less likely to help

Patients with advanced metastatic prostate cancer who are not candidates for cholesterol-lowering therapies may not receive benefit from this research.

What this research studies

This research investigates how lowering cholesterol levels may enhance the immune response against prostate cancer. It builds on previous findings that suggest a link between cholesterol-lowering therapies and reduced prostate cancer mortality. The study will involve both animal models and human clinical trials to explore how cholesterol reduction affects immune cells, particularly CD8+ T cells, which play a crucial role in fighting cancer. By understanding these mechanisms, the research aims to identify new strategies for improving cancer treatment outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that enhance the immune system's ability to fight prostate cancer.

How similar studies have gone: Previous studies have shown promising results linking cholesterol-lowering therapies with improved cancer outcomes, suggesting that this approach may be effective.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Kim, Hyung L — Cedars-Sinai Medical Center
  • Study coordinator: Kim, Hyung L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.